<DOC>
	<DOC>NCT01980810</DOC>
	<brief_summary>The purpose of this study is to determine whether albumine-bounded paclitaxel plus S-1 are effective in the treatment of advanced gastric or gastroesophageal junction adenocarcinoma.</brief_summary>
	<brief_title>First Line Chemotherapy for Advanced Cancer</brief_title>
	<detailed_description>This phase II study was designed to evaluate the efficacy and safety of albumin-bounded paclitaxel combined with S-1 as first-line chemotherapy for inoperable and /or metastatic gastric or gastroesophageal junction cancer.Primary endpoint was overall response rate.</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>Inoperable locally advanced, recurrent, and/or metastatic adenocarcinoma of the stomach or gastroesophageal junction Adult patients &gt;=18 years of age Performance Status Eastern Cooperative Oncology Group (ECOG) 02; At least have one measurable disease(according to RECIST) Adequate bone marrow,renal and liver function Previous chemotherapy for advanced/metastatic disease Lack of physical integrity of the upper gastrointestinal tract, or malabsorption syndrome</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>